FRIDAY, SEPTEMBER 4, 2026

DOWNLOAD PROGRAM

LIVE SURGERYGYNECOLOGIC ONCOLOGY

LIVE SURGERY
08.00 am to 12.00 pm | only in Essen, no live stream
THEATER 1 + 2:
BREAST SURGERY
New OP Procedures, Tips and Tricks for Solving Complications and Difficult Cases
Surgeons: J.-U. Blohmer, M. Warm, R. Skoblinow, T. Schnitzbauer, F. Hagemann, S. Kümmel, V. Bjelic-Radisic
Chair: M. Thill
THEATER 3 + 4:
GYNECOLOGIC ONCOLOGY
Radical Surgery in Ovarian Cancer, Sentinel Lymphadenectomy, Laparoscopic Techniques
Surgeons: G. D. Aletti, D. S. Chi, P. Harter, M. Moubarak
Chair: F. Hilpert, C. Grimm, C. Fotopoulou
THEATER 1 + 2:
BREAST SURGERY
New OP Procedures, Tips and Tricks for Solving Complications and Difficult Cases
Surgeons: J.-U. Blohmer, M. Warm, R. Skoblinow, T. Schnitzbauer, F. Hagemann, S. Kümmel, V. Bjelic-Radisic
Chair: M. Thill
THEATER 3 + 4:
GYNECOLOGIC ONCOLOGY
Radical Surgery in Ovarian Cancer, Sentinel Lymphadenectomy, Laparoscopic Techniques
Surgeons: G. D. Aletti, D. S. Chi, P. Harter, M. Moubarak
Chair: F. Hilpert, C. Grimm, C. Fotopoulou
12.00 pm
Lunch Break
Satellite Symposium - Abbvie
A Patient-Centered Journey: Individualized Treatment Options in Ovarian Cancer
Chair:  P. Harter
12.40 pm
Welcome and Introduction
P. Harter
12.45 pm
Defining the First Steps: Role of Surgery, Testing and Individualized Therapy at Primary Diagnosis and Platinum-Eligible Relapse
S. Mahner
01.00 pm
Classical Single Agent Chemotherapy will be Outdated soon: Era of New Options has Arrived in PROC
L. Hanker
01.15 pm
When Time Matters Most: Balancing Efficacy, Quality of Life and Time Toxicity in Platinum-Resistant Ovarian Cancer
F. Hilpert
01.30 pm
Panel Discussion
L. Hanker, F. Hilpert, P. Harter, S. Mahner
With the kind support of AbbVie Deutschland GmbH & Co. KG

GYNECOLOGIC ONCOLOGY

Ovarian Cancer
Chair:  D. S. Chi, P. Harter, S. Mahner
01.40 pm
TRUST: Which Patients are Clear Candidates for Primary Debulking Surgery?
C. Fotopoulou
01.55 pm
TRUST: Further Arguments to Use Neoadjuvant Chemotherapy?
T. van Gorp
02.10 pm
Anastomotic Leakage - Diagnosis and Management
G. D. Aletti
02.25 pm
Tumor Board Ovarian Cancer
Case presentation: T. Westermann
Discussant: N. Colombo
02.45 pm
Q&A Session
D. S. Chi, P. Harter, S. Mahner, C. Fotopoulou, T. van Gorp, G. D. Aletti, T. Westermann, N. Colombo
03.00 pm
Coffee Break
Satellite Symposium - Corcept
Breaking Through Resistance: New and Evolving Treatment Strategies in Platinum-Resistant Ovarian Cancer
Chair:  P. Harter
03.30 pm
Welcome & Introductions
P. Harter
03.35 pm
Where Are We Now? The Current Treatment Landscape and Unment Needs in PROC
P. Harter
03.45 pm
Shifting the Paradigm in PROC: Emerging Pathways and Expanding Options
F. Marmé
04.00 pm
Targeting Glucocorticoid Receptor-DrivenResistance: Emerging Evidence and Clinical Relevvance
D. Lorusso
04.20 pm
Panel Discussion & Audience Q&A
P. Harter, F. Marmé, D. Lorusso
With the kind support of Corcept Therapeutics Incorporated
GynOnc I
Chair:  D. Lorusso, T. van Gorp
04.30 pm
How to Integrate ICON 8B and HIPEC in Our Standard Recommendations for Systemic Therapy in Advanced Ovarian Cancer
A. González-Martín
04.42 pm
And What’s Next in Systemic Therapy for Ovarian Cancer?
I. Ray-Coquard
04.54 pm
Indications for Adjuvant Chemotherapy in Endometrial Cancer
N. Concin
05.06 pm
Tumor Board Endometrial Cancer
Case presentation: A. Strojna
Discussant: C. Marth
05.23 pm
Q&A Session
A. González-Martín, I. Ray-Coquard, N. Concin, A. Strojna, C. Marth, D. Lorusso, T. van Gorp
05.35 pm
Coffee Break
GynOnc II
Chair:  I. Ray-Coquard, A. González-Martín
05.50 pm
ESGO Presidential Lecture: Gynoncology: New Perspectives and Future Directions
J. Sehouli
06.02 pm
Management of Gynecologic Cancers in Pregnancy
I. Tsibulak
06.15 pm
Tumor Board Cervical Cancer
Case presentation: M. Bommert
Discussant: C. Grimm
06.31 pm
Q&A Session
J. Sehouli, I. Tsibulak, M. Bommert, C. Grimm, I. Ray-Coquard, A. González-Martín
Status: July 2026, may be subject to change